| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |